Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Alkermes Plc
(NQ:
ALKS
)
27.88
-0.16 (-0.57%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Alkermes Plc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
56 Biggest Movers From Yesterday
February 17, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...
Via
Benzinga
Why Are Alkermes Shares Trading Higher Today?
February 16, 2022
Alkermes plc's (NASDAQ: ALKS) Q4 sales increased 16% Y/Y to $324.5 million, beating the consensus of $308.69 million. Net sales of proprietary products were $178.9...
Via
Benzinga
40 Stocks Moving In Wednesday's Mid-Day Session
February 16, 2022
Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral...
Via
Benzinga
The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
February 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...
Via
Benzinga
Recap: Alkermes Q4 Earnings
February 16, 2022
Alkermes (NASDAQ:ALKS) reported its Q4 earnings results on Wednesday, February 16, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Earnings Scheduled For February 16, 2022
February 16, 2022
Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million.
Via
Benzinga
Earnings Preview For Alkermes
February 15, 2022
Alkermes (NASDAQ:ALKS) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that Alkermes will...
Via
Benzinga
The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More
February 13, 2022
Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...
Via
Benzinga
Alkermes Has Launched Employee Resource Groups
December 07, 2021
SOURCE: Alkermes
Via
3BL Media
Alkermes Schizophrenia Med Shows Lower Mean Weight Gain In Early Illness With Schizophrenia
February 08, 2022
Alkermes plc's (NASDAQ: ALKS) ENLIGHTEN-Early Phase 3b study of Lybalvi (olanzapine & samidorphan)
Via
Benzinga
The Daily Biotech Pulse: Pfizer, Amgen Shares Slip On Earnings, Editas Terminates Chief Medical Officer, Biogen Licenses Preclinical Rheumatoid Arthritis Biosimilar
February 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
BioCorRx Aims To Help Combat Opioid Crisis With Implantable Naltrexone Drug Candidate BICX104
January 24, 2022
Image provided by BioCorRx of a naltrexone pellet This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be...
Via
Benzinga
The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug
January 20, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Eisai Announces Publication Of Positive Data On Lenvima-Keytruda Combo In...
Via
Benzinga
One Overdose Is Too Many
November 29, 2021
SOURCE: Alkermes
Via
3BL Media
Benzinga's Top Ratings Upgrades, Downgrades For January 27, 2022
January 27, 2022
Upgrades
Via
Benzinga
Early Monday Report - More Moves Out Of China
January 09, 2022
Before it even turned Monday in the West, China insurers are feeling the heat.
Via
Talk Markets
Happy New Year - Sunday Edition
January 02, 2022
Starting a new year - we look at tech, pharma and mining stocks and their goings-on.
Via
Talk Markets
Our Collective Responsibility to Respond Effectively to the Climate Crisis
December 03, 2021
SOURCE: Alkermes
Via
3BL Media
Benzinga's Top Ratings Upgrades, Downgrades For December 1, 2021
December 01, 2021
Upgrades Goldman Sachs upgraded the previous rating for Grupo Aeroportuario del Sureste SAB de CV
Via
Benzinga
Alkermes in Action: Giving Tuesday
November 30, 2021
SOURCE: Alkermes
Via
3BL Media
Exposures
COVID-19
Alkermes Celebrates National Family Caregivers Month
November 24, 2021
SOURCE: Alkermes
Via
3BL Media
75 Biggest Movers From Yesterday
November 10, 2021
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep. Check out these big penny stock gainers and losers...
Via
Benzinga
Janssen Partially Terminates Nanoparticle License Agreement With Alkermes
November 09, 2021
Alkermes plc (NASDAQ: ALKS) stock is trading lower after announcing that Janssen, a unit of Johnson & Johnson (NYSE: JNJ), has provided notice of its...
Via
Benzinga
Why Alkermes Stock Is Sinking Today
November 09, 2021
Johnson & Johnson partly ended two licensing agreements with the company.
Via
The Motley Fool
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
7 A-Rated Healthcare Stocks to Buy for the Long Haul
November 01, 2021
It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future.
Via
InvestorPlace
10 Biggest Price Target Changes For Thursday
October 28, 2021
Oppenheimer lowered Teladoc Health, Inc. (NYSE:TDOC
Via
Benzinga
Alkermes plc (ALKS) Q3 2021 Earnings Call Transcript
October 27, 2021
ALKS earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Cyber Currency
October 26, 2021
Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.
Via
Talk Markets
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
October 27, 2021
Palm Beach, FL –October 27, 2021 – FinancialNewsMedia.com News Commentary – Among the race to see what psychedelic drugs can do, ketamine is a step ahead of all other drugs, because it has already been...
Via
FinancialNewsMedia
Exposures
Product Safety
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.